gdc

December 2021 Vol 7 No 6

Cancer Concerns Drift Away While I Focus on My Painting
Art TherapyMultiple Myeloma
While painting this beautifully realistic rendition of a Clam Shack in Cape Cod, Eddie Sutherland was able to step back, focus on his art, and forget his cancer concerns for a while.
Tecartus, a Gene Therapy, Now Approved for Patients with Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia
FDA Approvals, News & UpdatesLeukemia
In October 2021, the FDA approved a second indication for Tecartus (brexucabtagene autoleucel), a novel, genetically modified CAR T-cell therapy, for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Scemblix a New Oral Therapy Approved for Patients with Chronic Myeloid Leukemia
FDA Approvals, News & UpdatesLeukemia
In October 2021, the FDA approved Scemblix (asciminib) for patients with chronic-phase Ph-positive chronic myeloid leukemia (CML) or CML associated with T315I mutation. Scemblix is a new type of drug that may improve outcomes over other therapies for some patients with CML.
Keytruda plus Chemotherapy FDA Approved for First-Line Treatment of Cervical Cancer
FDA Approvals, News & UpdatesCervical Cancer
In October 2021, the FDA approved the immunotherapy Keytruda (pembrolizumab), in combination with chemotherapy and with or without Avastin (bevacizumab), for patients with persistent, recurrent, or metastatic cervical cancer and PD-L1 expression.
When Should You Reach Out to Your Navigator?
From Your NavigatorSupport Services
Oncology navigator Sharon Gentry, RN, MSN, explains the value of reaching out to your navigator. A large part of the navigator’s job is to answer questions related to patient care, from transportation and insurance coverage options to cultural concerns, and everything in between.
Keytruda FDA Approved for Adjuvant Treatment of Kidney Cancer
Kidney CancerFDA Approvals, News & Updates
In November 2021, the FDA approved a new indication for the immunotherapy Keytruda (pembrolizumab) for adjuvant treatment (after surgery) of patients with renal-cell carcinoma that is at intermediate-high or high risk for recurrence.
Providing Men a New, Safer Way of Diagnosing Prostate Cancer
Men's HealthProstate CancerDiagnosis
Dr. Matthew Allaway is a testicular cancer survivor and a practicing urologist. He describes a new procedure he created to ease the difficulty of diagnosing prostate cancer, the most common cancer among men in the United States.
Cancer and Grief
Grief Management Mental Health
Grief Counselor Kelly Grosklags says that being authentic in a world that stigmatizes mental health and judges raw emotions can be lonely and alienating. She provides tips on how to deal with some of the feelings that come with the layers of loss and mourning.
Fighting Cancer Amid a Pandemic: My Cross-Country Clinical Trial Experience
Patient StoriesGastric CancerClinical Trials
At age 68, Dan Greene was told the intense pain in his abdomen was likely pancreatic cancer, until further testing determined he had stage IV stomach cancer. Joining a clinical trial gave him a second chance.
Why Men with Cancer Don’t Seek Support: Fear of Vulnerability and Lack of Power
Men's Health
Many men hid their emotions and vulnerability in an effort to maintain a sense of manliness or power, but suffering in silence can have drastic implications for men’s health and make cancer treatment more difficult.
Page 1 of 3
Results 1 - 10 of 23

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest